1 Executive Summary
- 1.1 Market overview
- Executive Summary – Chart on Market Overview
- Executive Summary – Data Table on Market Overview
- Executive Summary – Chart on Global Market Characteristics
- Executive Summary – Chart on Market by Geography
- Executive Summary – Chart on Market Segmentation by Product
- Executive Summary – Chart on Market Segmentation by End-user
- Executive Summary – Chart on Incremental Growth
- Executive Summary – Data Table on Incremental Growth
- Executive Summary – Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on – Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
- Value Chain Analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global – Market size and forecast 2023-2028 ($ million)
- Data Table on Global – Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Digital Therapeutics Market 2018 – 2022
- Historic Market Size – Data Table on Global Digital Therapeutics Market 2018 – 2022 ($ million)
- 4.2 Product segment analysis 2018 – 2022
- Historic Market Size – Product Segment 2018 – 2022 ($ million)
- 4.3 End-user segment analysis 2018 – 2022
- Historic Market Size – End-user Segment 2018 – 2022 ($ million)
- 4.4 Geography segment analysis 2018 – 2022
- Historic Market Size – Geography Segment 2018 – 2022 ($ million)
- 4.5 Country segment analysis 2018 – 2022
- Historic Market Size – Country Segment 2018 – 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis – Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers – Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers – Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants – Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes – Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry – Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition – Five forces 2023 and 2028
6 Market Segmentation by Product
- 6.1 Market segments
- Chart on Product – Market share 2023-2028 (%)
- Data Table on Product – Market share 2023-2028 (%)
- 6.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 6.3 Software – Market size and forecast 2023-2028
- Chart on Software – Market size and forecast 2023-2028 ($ million)
- Data Table on Software – Market size and forecast 2023-2028 ($ million)
- Chart on Software – Year-over-year growth 2023-2028 (%)
- Data Table on Software – Year-over-year growth 2023-2028 (%)
- 6.4 Devices – Market size and forecast 2023-2028
- Chart on Devices – Market size and forecast 2023-2028 ($ million)
- Data Table on Devices – Market size and forecast 2023-2028 ($ million)
- Chart on Devices – Year-over-year growth 2023-2028 (%)
- Data Table on Devices – Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by End-user
- 7.1 Market segments
- Chart on End-user – Market share 2023-2028 (%)
- Data Table on End-user – Market share 2023-2028 (%)
- 7.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 7.3 Business-to-Consumer – Market size and forecast 2023-2028
- Chart on Business-to-Consumer – Market size and forecast 2023-2028 ($ million)
- Data Table on Business-to-Consumer – Market size and forecast 2023-2028 ($ million)
- Chart on Business-to-Consumer – Year-over-year growth 2023-2028 (%)
- Data Table on Business-to-Consumer – Year-over-year growth 2023-2028 (%)
- 7.4 Business-to-Business – Market size and forecast 2023-2028
- Chart on Business-to-Business – Market size and forecast 2023-2028 ($ million)
- Data Table on Business-to-Business – Market size and forecast 2023-2028 ($ million)
- Chart on Business-to-Business – Year-over-year growth 2023-2028 (%)
- Data Table on Business-to-Business – Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America – Market size and forecast 2023-2028
- Chart on North America – Market size and forecast 2023-2028 ($ million)
- Data Table on North America – Market size and forecast 2023-2028 ($ million)
- Chart on North America – Year-over-year growth 2023-2028 (%)
- Data Table on North America – Year-over-year growth 2023-2028 (%)
- 9.4 Europe – Market size and forecast 2023-2028
- Chart on Europe – Market size and forecast 2023-2028 ($ million)
- Data Table on Europe – Market size and forecast 2023-2028 ($ million)
- Chart on Europe – Year-over-year growth 2023-2028 (%)
- Data Table on Europe – Year-over-year growth 2023-2028 (%)
- 9.5 Asia – Market size and forecast 2023-2028
- Chart on Asia – Market size and forecast 2023-2028 ($ million)
- Data Table on Asia – Market size and forecast 2023-2028 ($ million)
- Chart on Asia – Year-over-year growth 2023-2028 (%)
- Data Table on Asia – Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
- Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
- 9.7 US – Market size and forecast 2023-2028
- Chart on US – Market size and forecast 2023-2028 ($ million)
- Data Table on US – Market size and forecast 2023-2028 ($ million)
- Chart on US – Year-over-year growth 2023-2028 (%)
- Data Table on US – Year-over-year growth 2023-2028 (%)
- 9.8 UK – Market size and forecast 2023-2028
- Chart on UK – Market size and forecast 2023-2028 ($ million)
- Data Table on UK – Market size and forecast 2023-2028 ($ million)
- Chart on UK – Year-over-year growth 2023-2028 (%)
- Data Table on UK – Year-over-year growth 2023-2028 (%)
- 9.9 Germany – Market size and forecast 2023-2028
- Chart on Germany – Market size and forecast 2023-2028 ($ million)
- Data Table on Germany – Market size and forecast 2023-2028 ($ million)
- Chart on Germany – Year-over-year growth 2023-2028 (%)
- Data Table on Germany – Year-over-year growth 2023-2028 (%)
- 9.10 Canada – Market size and forecast 2023-2028
- Chart on Canada – Market size and forecast 2023-2028 ($ million)
- Data Table on Canada – Market size and forecast 2023-2028 ($ million)
- Chart on Canada – Year-over-year growth 2023-2028 (%)
- Data Table on Canada – Year-over-year growth 2023-2028 (%)
- 9.11 China – Market size and forecast 2023-2028
- Chart on China – Market size and forecast 2023-2028 ($ million)
- Data Table on China – Market size and forecast 2023-2028 ($ million)
- Chart on China – Year-over-year growth 2023-2028 (%)
- Data Table on China – Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
12 Competitive Analysis
- 12.1 Companies profiled
- Companies covered
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 2Morrow Inc.
- 2Morrow Inc. – Overview
- 2Morrow Inc. – Product / Service
- 2Morrow Inc. – Key offerings
- 12.4 Akili Inc.
- Akili Inc. – Overview
- Akili Inc. – Product / Service
- Akili Inc. – Key offerings
- 12.5 Alphabet Inc.
- Alphabet Inc. – Overview
- Alphabet Inc. – Business segments
- Alphabet Inc. – Key offerings
- Alphabet Inc. – Segment focus
- 12.6 BigHealth
- BigHealth – Overview
- BigHealth – Product / Service
- BigHealth – Key offerings
- 12.7 Canary Health
- Canary Health – Overview
- Canary Health – Product / Service
- Canary Health – Key offerings
- 12.8 DarioHealth Corp.
- DarioHealth Corp. – Overview
- DarioHealth Corp. – Product / Service
- DarioHealth Corp. – Key offerings
- 12.9 Digital Therapeutics Alliance Inc.
- Digital Therapeutics Alliance Inc. – Overview
- Digital Therapeutics Alliance Inc. – Product / Service
- Digital Therapeutics Alliance Inc. – Key offerings
- 12.10 GAIA AG
- GAIA AG – Overview
- GAIA AG – Product / Service
- GAIA AG – Key offerings
- 12.11 Limbix Health Inc.
- Limbix Health Inc. – Overview
- Limbix Health Inc. – Product / Service
- Limbix Health Inc. – Key offerings
- 12.12 Noom Inc.
- Noom Inc. – Overview
- Noom Inc. – Product / Service
- Noom Inc. – Key offerings
- 12.13 Omada Health Inc.
- Omada Health Inc. – Overview
- Omada Health Inc. – Product / Service
- Omada Health Inc. – Key offerings
- 12.14 Pear Therapeutics Inc.
- Pear Therapeutics Inc. – Overview
- Pear Therapeutics Inc. – Product / Service
- Pear Therapeutics Inc. – Key offerings
- 12.15 ResMed Inc.
- ResMed Inc. – Overview
- ResMed Inc. – Business segments
- ResMed Inc. – Key news
- ResMed Inc. – Key offerings
- ResMed Inc. – Segment focus
- 12.16 Teladoc Health Inc.
- Teladoc Health Inc. – Overview
- Teladoc Health Inc. – Product / Service
- Teladoc Health Inc. – Key offerings
- 12.17 WellDoc Inc.
- WellDoc Inc. – Overview
- WellDoc Inc. – Product / Service
- WellDoc Inc. – Key offerings
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- Research methodology
- 13.5 Data procurement
- Information sources
- 13.6 Data validation
- Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
- List of abbreviations
Digital Therapeutics Market Size 2024-2028
The Digital Therapeutics Market size is forecast to increase by USD 19.17 billion, at a CAGR of 32.59% between 2023 and 2028. The market growth is primarily being fuelled by several factors. These include the rising occurrence of chronic diseases, technological advancements in digital therapeutics, and the widespread use of smartphones and connected devices. However, challenges such as high development and regulatory costs, as well as limited reimbursement and insurance coverage, could potentially impede the market’s progress. Nevertheless, there are positive trends that are expected to contribute significantly to the market’s exponential growth. These include the increasing adoption of personalized and adaptive interventions, as well as the integration of artificial intelligence and machine learning into digital therapeutics.
What will be the Size of the Market During the Forecast Period?
Who are the Major Market Players?
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
- Akili interactive: The company offers digital therapeutics that deliver specific sensory stimuli and simultaneous motor challenges designed to target neural systems involved in attentional control.
The market forecasting research report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including
- Alphabet Inc.
- Better Therapeutics Inc.
- BigHealth
- Brain+ ApS
- Canary Health
- Click Therapeutics Inc
- Digital Therapeutics Alliance Inc.
- GAIA AG
- Jogo Health Inc.
- Limbix Health Inc.
- Medtronic Plc
- Noom Inc.
- Omada Health Inc.
- Pear Therapeutics Inc.
- ResMed Inc.
- Teladoc Health Inc.
- WellDoc Inc.
- DarioHealth Corp.
Qualitative and quantitative market research and growth analysis of companies have been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. In the market growth analysis, data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
Market Segmentation
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in “USD Billion” for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
- Product Outlook
- Software
- Devices
- End-user Outlook
- Business-to-consumer (B2C)
- Business-to-business (B2B)
- Region Outlook
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- ROW
- Australia
- Argentina
- Brazil
- North America
By Product
The market share growth by the software segment will be significant during the forecast period. The global market is experiencing significant growth for software as a product. Software products are becoming dominant in providing efficient and individualized healthcare interventions as a result of the increasing usage of these solutions.
Get a glance at the market contribution of various segments View the PDF Sample
The software segment was valued at USD 1.83 billion in 2018. Numerous variety of software products, such as mobile applications, web-based platforms, and virtual coaching tools, are available in the market in focus. To enhance the overall user experience, providers are concentrating on creating intuitive user interfaces, sophisticated analytics tools, and interoperability features. Software products are an important aspect of the emerging field of digital therapeutics due to partnerships and collaborations between healthcare organizations and software developers that improve innovation and broaden market reach. Hence, owing to the rising demand for this software, the market in focus is expected to witness significant growth during the forecast period.
Which are the Key Regions for the Market?
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In 2022, the North American market witnessed significant growth. Government initiatives in the region have been essential in enhancing the integration into healthcare delivery systems. Healthcare professionals and patients now have more confidence, which has encouraged the adoption of digital therapeutics. The market in North America is anticipated to continue growing during the forecast period due to the rising importance of the demand for affordable treatment solutions and patient-centered care. Digital therapeutic solutions have been aggressively developed and promoted by manufacturers in North America. To give efficient interventions, they have been utilizing cutting-edge technology like AI, machine learning (ML), and data analytics.
Market Dynamics and Customer Landscape
The Digital Therapeutics (DTx) Market is witnessing an increase driven by a paradigm shift towards preventative healthcare and the management of preventable chronic diseases. Despite reluctance among patients, there’s an increasing adoption of mHealth applications and smart health-tracking technologies, bolstered by rising smartphone penetration and digital literacy. Clinical validation and integration into healthcare infrastructure underscore the importance of digital health technology. Venture capital investment and initiatives by organizations like the GSM Association further propel the market. With a focus on patient-centric care and patient retention, the market addresses chronic conditions like obesity and cardiovascular disorders, paving the way for integrated healthcare systems and software-based medical devices (SaMD).
Key Market Driver
The increasing prevalence of chronic diseases is a key driver of the market. With the rising incidence of chronic illnesses globally, there is a growing need for affordable and efficient treatment alternatives. Chronic diseases, including cardiovascular conditions, diabetes, and mental health issues, are major contributors to global mortality and morbidity, as highlighted by the World Health Organization. In response to this challenge, these therapeutics offer a promising approach to enhance patient outcomes and reduce healthcare costs. These digital treatments deliver evidence-based interventions through mobile applications, wearables, and other technologies, empowering patients to better manage their chronic diseases and achieve improved health outcomes.
As the prevalence of chronic diseases continues to rise, the demand for such therapeutics is also expected to grow. Consequently, the market is poised for significant expansion during the forecast period, driven by the increasing need for effective solutions to manage chronic conditions.
Key Market Trends
The market trends is experiencing significant growth due to the increasing adoption of personalized and adaptive interventions. These solutions utilize data analytics, artificial intelligence, and machine learning to deliver customized treatment programs that cater to individual patient needs, interests, and lifestyles. For instance, companies like Happify Health and Pear Therapeutics offer personalized mental health interventions for patients with substance use disorders using cognitive-behavioral therapy and mindfulness techniques.
Thus, aligned with market trends and analysis, such tailored interventions provide patients with more effective and engaging treatment options, leading to improved health outcomes. As the demand for personalized solutions rises, the market is expected to continue its upward trajectory during the forecast period.
Major Market Challenge
High development and regulatory costs are one of the key challenges hindering market growth. The major costs associated with product development and regulatory compliance are some of the main challenges the global market for these solutions must overcome. A sizable initial expenditure is needed for research and development, clinical trials, and regulatory filings to establish digital medicine.
Additionally, getting regulatory approval from organizations like the FDA can be an expensive and time-consuming process. Smaller businesses may be particularly burdened by these expenses, which inhibits market innovation and competitiveness. As a result, businesses could find it unfavorable to become profitable and obtain financing. Access to cutting-edge remedies is hampered by the high development costs involved with digital pharmaceuticals, which act as a significant barrier to the entry of new players. Hence, regulatory costs and high development are challenges that can hinder the growth of the market in focus during the forecast period.
Market Customer Landscape
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
Market Analyst Overview
The market is witnessing rapid growth globally, driven by advancements in digital health technology and its integration into healthcare systems. Both developed and developing economies are embracing smart health tracking and patient-centric care, fostering the adoption. Integrated healthcare systems leverage mobile services, with a significant portion of the global population owning smartphones. This widespread penetration supports the growth of mHealth applications, emphasizing regulatory flexibility.
Moreover, the market is undergoing a transformative phase, driven by the urgent need to address chronic conditions like CNS disease and cancer. Despite challenges such as reluctance among patients and varying technology literacy levels, the market is bolstered by clinical validation and integration into healthcare infrastructure. As healthcare costs escalate due to preventable chronic diseases, there’s a growing focus on preventative healthcare and leveraging electronic health records to facilitate patient retention. Increasing phone penetration and internet penetration offer opportunities for wider adoption, attracting venture capital investment and fostering behavioral change towards better health outcomes.
Further, digital health products address various health conditions, including cardiovascular disorders, chronic kidney disease, chronic lung disease, Alzheimer’s, obesity, smoking cessation, and central nervous system (CNS) diseases. Regulatory initiatives, such as the FDA’s Digital Health Innovation Action Plan, contribute to standardization and the development of software-based medical devices (SaMD). With a focus on personalized healthcare, the market is poised for continued expansion, offering innovative solutions to improve patient outcomes and address diverse health challenges.
